{"transactions":[{"id":728021,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T22:05:45.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":5277,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying the stock option vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date."}],"balance_after":5277,"derivative":{"exercise_price":68.92,"expiration_date":"2036-06-21","underlying":"Common Stock","underlying_shares":5277},"source":{"system":"sec-edgar","filing":"0001470831-26-000629","document":"wk-form4_1782338741.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000147083126000629/wk-form4_1782338741.xml","form_type":"4"}},{"id":728020,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-24T22:05:45.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":3990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Grant of restricted stock units (\"RSUs\") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":29879,"source":{"system":"sec-edgar","filing":"0001470831-26-000629","document":"wk-form4_1782338741.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000147083126000629/wk-form4_1782338741.xml","form_type":"4"}},{"id":842192,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-03-16T21:08:48.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":false,"shares":71839,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested in full on March 13, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested in full on March 13, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":71839},"source":{"system":"sec-edgar","filing":"0000950103-26-003833","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000095010326003833/ownership.xml","form_type":"4"}},{"id":842191,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-16T21:08:48.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":true,"shares":71839,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."}],"balance_after":1243239,"source":{"system":"sec-edgar","filing":"0000950103-26-003833","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000095010326003833/ownership.xml","form_type":"4"}},{"id":846828,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock (Right to Buy)","published_at":"2026-03-12T20:26:27.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":41073,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":41073,"derivative":{"exercise_price":3.51,"exercise_date":"2026-03-10","expiration_date":"2036-03-10","underlying":"Common Stock","underlying_shares":41073},"source":{"system":"sec-edgar","filing":"0000950103-26-003687","document":"dp243215_4-hassan.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000095010326003687/dp243215_4-hassan.xml","form_type":"4"}},{"id":846827,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-03-12T20:26:27.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":35612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in full on March 10, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in full on March 10, 2027."}],"balance_after":35612,"derivative":{"underlying":"Common Stock","underlying_shares":35612},"source":{"system":"sec-edgar","filing":"0000950103-26-003687","document":"dp243215_4-hassan.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000095010326003687/dp243215_4-hassan.xml","form_type":"4"}},{"id":846826,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-12T20:26:27.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":17948,"price":3.51,"value":62997.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued to the reporting person in lieu of an annual retainer of $63,000."}],"balance_after":1171400,"source":{"system":"sec-edgar","filing":"0000950103-26-003687","document":"dp243215_4-hassan.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000095010326003687/dp243215_4-hassan.xml","form_type":"4"}},{"id":940302,"issuer":{"id":7621,"kind":"organization","name":"Cocrystal Pharma, Inc."},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-01-13T21:10:08.000Z","date":"2026-01-09","kind":"grant","planned":false,"acquired":true,"shares":16410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Compensation Committee of the Board of Directors. The non-qualified stock options are granted under the Issuer's 2025 Equity Incentive Plan and the exercisability shall be subject to execution of the Issuer's form of Non-Qualified Stock Option Agreement. The non-qualified stock options shall vest as follows: one-half shall vest and become exercisable on January 9, 2027 and the remaining half shall vest and become exercisable in eight equal quarterly installments commencing on March 31, 2027, subject to the Reporting Person continuing to serve as a director of the Issuer on each applicable vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Compensation Committee of the Board of Directors. The non-qualified stock options are granted under the Issuer's 2025 Equity Incentive Plan and the exercisability shall be subject to execution of the Issuer's form of Non-Qualified Stock Option Agreement. The non-qualified stock options shall vest as follows: one-half shall vest and become exercisable on January 9, 2027 and the remaining half shall vest and become exercisable in eight equal quarterly installments commencing on March 31, 2027, subject to the Reporting Person continuing to serve as a director of the Issuer on each applicable vesting date."}],"balance_after":16410,"derivative":{"exercise_price":1.1,"expiration_date":"2036-01-09","underlying":"Common Stock","underlying_shares":16410},"source":{"system":"sec-edgar","filing":"0001493152-26-002037","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000149315226002037/ownership.xml","form_type":"4"}},{"id":947615,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T21:06:32.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40000,"derivative":{"exercise_price":17.48,"exercise_date":"2027-01-02","expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001110744-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000111074426000002/primarydocument.xml","form_type":"4"}},{"id":1011503,"issuer":{"id":7621,"kind":"organization","name":"Cocrystal Pharma, Inc."},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2025-10-30T20:15:23.000Z","date":"2025-10-28","kind":"grant","planned":false,"acquired":true,"shares":719426,"price":1.39,"value":1000002.14,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Reporting Person purchased units at $1.39 per unit with each unit consisting of one share of common stock and a warrant to purchase two shares of common stock. The shares of common stock and warrants purchased are exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 thereunder, as it was approved by a Special Committee of the Board of Directors of the Issuer, which Special Committee consisted of two non-employee directors. The warrants were exercisable upon issuance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person purchased units at $1.39 per unit with each unit consisting of one share of common stock and a warrant to purchase two shares of common stock. The shares of common stock and warrants purchased are exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 thereunder, as it was approved by a Special Committee of the Board of Directors of the Issuer, which Special Committee consisted of two non-employee directors. The warrants were exercisable upon issuance."}],"balance_after":719426,"derivative":{"exercise_price":1.24,"expiration_date":"2028-01-28","underlying":"Common Stock","underlying_shares":719426},"source":{"system":"sec-edgar","filing":"0001493152-25-020221","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000149315225020221/ownership.xml","form_type":"4"}},{"id":1011502,"issuer":{"id":7621,"kind":"organization","name":"Cocrystal Pharma, Inc."},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-30T20:15:23.000Z","date":"2025-10-28","kind":"grant","planned":false,"acquired":true,"shares":359713,"price":1.39,"value":500001.07,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Reporting Person purchased units at $1.39 per unit with each unit consisting of one share of common stock and a warrant to purchase two shares of common stock. The shares of common stock and warrants purchased are exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 thereunder, as it was approved by a Special Committee of the Board of Directors of the Issuer, which Special Committee consisted of two non-employee directors. The warrants were exercisable upon issuance."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock issuable upon vesting of restricted stock units."}],"balance_after":1383009,"source":{"system":"sec-edgar","filing":"0001493152-25-020221","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000149315225020221/ownership.xml","form_type":"4"}},{"id":1102970,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-24T22:56:17.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":8425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of the shares underlying the stock option will vest each year after June 20, 2025, such that all of the underlying shares will be vested on June 20, 2028, subject to the Reporting Person's continued service on the Issuer's board of directors."}],"balance_after":8425,"derivative":{"exercise_price":41.73,"expiration_date":"2035-06-19","underlying":"Common Stock","underlying_shares":8425},"source":{"system":"sec-edgar","filing":"0000950170-25-089647","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000095017025089647/ownership.xml","form_type":"4"}},{"id":1102969,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T22:56:17.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":6589,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Grant of restricted stock units (\"RSUs\") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan.  One-third of the RSUs will vest each year after June 20, 2025, such that all of the units will be vested on June 20, 2028, subject to the Reporting Person's continued service on the Issuer's board of directors."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":25889,"source":{"system":"sec-edgar","filing":"0000950170-25-089647","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000095017025089647/ownership.xml","form_type":"4"}},{"id":1204367,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock (Right to Buy)","published_at":"2025-03-17T22:33:13.000Z","date":"2025-03-13","kind":"grant","planned":false,"acquired":true,"shares":83517,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":83517,"derivative":{"exercise_price":1.74,"exercise_date":"2025-03-13","expiration_date":"2035-03-13","underlying":"Common Stock","underlying_shares":83517},"source":{"system":"sec-edgar","filing":"0000950103-25-003518","document":"dp226401_4-hassan.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000095010325003518/dp226401_4-hassan.xml","form_type":"4"}},{"id":1204366,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-03-17T22:33:13.000Z","date":"2025-03-14","kind":"exercise","planned":false,"acquired":false,"shares":87412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested in full on March 14, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested in full on March 14, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":87412},"source":{"system":"sec-edgar","filing":"0000950103-25-003518","document":"dp226401_4-hassan.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000095010325003518/dp226401_4-hassan.xml","form_type":"4"}},{"id":1204365,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-03-17T22:33:13.000Z","date":"2025-03-13","kind":"grant","planned":false,"acquired":true,"shares":71839,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in full on March 13, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in full on March 13, 2026."}],"balance_after":71839,"derivative":{"underlying":"Common Stock","underlying_shares":71839},"source":{"system":"sec-edgar","filing":"0000950103-25-003518","document":"dp226401_4-hassan.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000095010325003518/dp226401_4-hassan.xml","form_type":"4"}},{"id":1204364,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-17T22:33:13.000Z","date":"2025-03-14","kind":"exercise","planned":false,"acquired":true,"shares":87412,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."}],"balance_after":1153452,"source":{"system":"sec-edgar","filing":"0000950103-25-003518","document":"dp226401_4-hassan.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000095010325003518/dp226401_4-hassan.xml","form_type":"4"}},{"id":1204363,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-17T22:33:13.000Z","date":"2025-03-13","kind":"grant","planned":false,"acquired":true,"shares":36206,"price":1.74,"value":62998.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued to the reporting person in lieu of an annual retainer of $63,000."}],"balance_after":1066040,"source":{"system":"sec-edgar","filing":"0000950103-25-003518","document":"dp226401_4-hassan.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000095010325003518/dp226401_4-hassan.xml","form_type":"4"}},{"id":1308539,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-07T21:05:12.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40000,"derivative":{"exercise_price":8.26,"exercise_date":"2026-01-03","expiration_date":"2035-01-03","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001562180-25-000235","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000156218025000235/primarydocument.xml","form_type":"4"}},{"id":1387687,"issuer":{"id":7621,"kind":"organization","name":"Cocrystal Pharma, Inc."},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-11T20:05:52.000Z","date":"2024-10-09","kind":"grant","planned":false,"acquired":true,"shares":8067,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The grant is exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 thereunder, as it was approved by the Board of Directors of the Issuer. One half of the RSUs are fully vested, with the balance vesting in eight equal quarterly installments on the last day of each quarter commencing with the quarter ending September 30, 2025, subject to continued services for the Company as of each applicable vesting date. Shares of common stock will be delivered to the Reporting Person promptly upon vesting, unless the Reporting Person elects to defer delivery. The RSUs were granted under the Issuer's 2015 Equity Incentive Plan and will vest in full upon a Change of Control as defined in such Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The grant is exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 thereunder, as it was approved by the Board of Directors of the Issuer. One half of the RSUs are fully vested, with the balance vesting in eight equal quarterly installments on the last day of each quarter commencing with the quarter ending September 30, 2025, subject to continued services for the Company as of each applicable vesting date. Shares of common stock will be delivered to the Reporting Person promptly upon vesting, unless the Reporting Person elects to defer delivery. The RSUs were granted under the Issuer's 2015 Equity Incentive Plan and will vest in full upon a Change of Control as defined in such Plan."}],"balance_after":1023296,"source":{"system":"sec-edgar","filing":"0001493152-24-040899","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000149315224040899/ownership.xml","form_type":"4"}},{"id":1414302,"issuer":{"id":5702,"kind":"organization","name":"EyePoint, Inc."},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-09-05T20:02:41.000Z","date":"2024-09-03","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable in three ratable annual installments beginning on September 3, 2025."}],"balance_after":60000,"derivative":{"exercise_price":8.16,"expiration_date":"2034-09-03","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001562180-24-006671","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000156218024006671/primarydocument.xml","form_type":"4"}},{"id":1469793,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-25T21:39:14.000Z","date":"2024-06-21","kind":"grant","planned":false,"acquired":true,"shares":26014,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares underlying the stock option will vest each year after June 21, 2024, such that all of the underlying shares will be vested on June 21, 2027, subject to the Reporting Person's continued service on the board of directors of the Issuer."}],"balance_after":26014,"derivative":{"exercise_price":27.36,"expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":26014},"source":{"system":"sec-edgar","filing":"0000950170-24-077444","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000095017024077444/ownership.xml","form_type":"4"}},{"id":1572915,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock (Right to Buy)","published_at":"2024-03-18T22:20:35.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":101626,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":101626,"derivative":{"exercise_price":1.43,"exercise_date":"2024-03-14","expiration_date":"2034-03-14","underlying":"Common Stock","underlying_shares":101626},"source":{"system":"sec-edgar","filing":"0000950103-24-003955","document":"dp208508_4-hassan.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000095010324003955/dp208508_4-hassan.xml","form_type":"4"}},{"id":1572914,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-03-18T22:20:35.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":87412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in full on March 14, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in full on March 14, 2025."}],"balance_after":87412,"derivative":{"underlying":"Common Stock","underlying_shares":87412},"source":{"system":"sec-edgar","filing":"0000950103-24-003955","document":"dp208508_4-hassan.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000095010324003955/dp208508_4-hassan.xml","form_type":"4"}},{"id":1572913,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-18T22:20:35.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":44055,"price":1.43,"value":62998.65,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued to the reporting person in lieu of an annual retainer of $62,999."}],"balance_after":1029834,"source":{"system":"sec-edgar","filing":"0000950103-24-003955","document":"dp208508_4-hassan.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000095010324003955/dp208508_4-hassan.xml","form_type":"4"}},{"id":1581924,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-03-12T23:53:24.000Z","date":"2024-03-09","kind":"exercise","planned":false,"acquired":false,"shares":106837,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested in full on March 9, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested in full on March 9, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":106837},"source":{"system":"sec-edgar","filing":"0000950103-24-003746","document":"dp208299_4-hassan.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000095010324003746/dp208299_4-hassan.xml","form_type":"4"}},{"id":1581923,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-12T23:53:24.000Z","date":"2024-03-09","kind":"exercise","planned":false,"acquired":true,"shares":106837,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."}],"balance_after":985779,"source":{"system":"sec-edgar","filing":"0000950103-24-003746","document":"dp208299_4-hassan.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000095010324003746/dp208299_4-hassan.xml","form_type":"4"}},{"id":1806266,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-16T20:31:16.000Z","date":"2023-08-14","kind":"purchase","planned":false,"acquired":true,"shares":570345,"price":1.75,"value":998103.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were purchased under an account held jointly by the reporting person and the reporting person's spouse."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.69 to $1.76, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":878942,"source":{"system":"sec-edgar","filing":"0000950103-23-012143","document":"dp198564_4-hassan.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000095010323012143/dp198564_4-hassan.xml","form_type":"4"}},{"id":1826021,"issuer":{"id":7621,"kind":"organization","name":"Cocrystal Pharma, Inc."},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-07-20T20:05:19.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":7333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options were issued pursuant to the 2015 Equity Incentive Plan and vest as follows: one-half will vest and become exercisable on July 18, 2024 and the remaining half will vest and become exercisable in eight equal quarterly installments on the last day of March, June, September, and December commencing on September 30, 2024, subject to the reporting person continuing to serve as a director of the Company on each applicable vesting date."}],"balance_after":7333,"derivative":{"exercise_price":2.67,"expiration_date":"2033-07-18","underlying":"Common Stock","underlying_shares":7333},"source":{"system":"sec-edgar","filing":"0001493152-23-025080","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000149315223025080/ownership.xml","form_type":"4"}},{"id":1845552,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-23T20:19:30.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":51501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3rd of the shares underlying the option will vest on June 21, 2024; thereafter, 1/3rd of the underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on June 21, 2026, subject to the optionee's continued service on the Board of Directors of the Company."}],"balance_after":51501,"derivative":{"exercise_price":16.75,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":51501},"source":{"system":"sec-edgar","filing":"0001209191-23-039375","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000120919123039375/doc4.xml","form_type":"4"}},{"id":1852910,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T20:00:16.000Z","date":"2023-06-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":21013,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. (\"Merck\") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the \"Effective Time\"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the \"Merger Consideration\"), without interest,.. (Continued in Footnote 3)"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units (\"RSUs\") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. (\"Merck\") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the \"Effective Time\"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the \"Merger Consideration\"), without interest,.. (Continued in Footnote 3)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"(Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units (\"RSUs\") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option."}],"balance_after":0,"derivative":{"exercise_price":29.02,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":21013},"source":{"system":"sec-edgar","filing":"0000899243-23-015758","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000089924323015758/doc4.xml","form_type":"4"}},{"id":1852909,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T20:00:16.000Z","date":"2023-06-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":541,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. (\"Merck\") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the \"Effective Time\"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the \"Merger Consideration\"), without interest,.. (Continued in Footnote 3)"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units (\"RSUs\") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. (\"Merck\") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the \"Effective Time\"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the \"Merger Consideration\"), without interest,.. (Continued in Footnote 3)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"(Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units (\"RSUs\") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option."}],"balance_after":0,"derivative":{"exercise_price":36.32,"expiration_date":"2031-11-13","underlying":"Common Stock","underlying_shares":541},"source":{"system":"sec-edgar","filing":"0000899243-23-015758","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000089924323015758/doc4.xml","form_type":"4"}},{"id":1852908,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T20:00:16.000Z","date":"2023-06-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. (\"Merck\") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the \"Effective Time\"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the \"Merger Consideration\"), without interest,.. (Continued in Footnote 3)"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units (\"RSUs\") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. (\"Merck\") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the \"Effective Time\"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the \"Merger Consideration\"), without interest,.. (Continued in Footnote 3)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"(Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units (\"RSUs\") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option."}],"balance_after":0,"derivative":{"exercise_price":16.82,"expiration_date":"2031-05-13","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000899243-23-015758","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000089924323015758/doc4.xml","form_type":"4"}},{"id":1852907,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T20:00:16.000Z","date":"2023-06-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2123,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. (\"Merck\") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the \"Effective Time\"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the \"Merger Consideration\"), without interest,.. (Continued in Footnote 3)"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units (\"RSUs\") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-015758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000089924323015758/doc4.xml","form_type":"4"}},{"id":1885349,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-19T21:39:34.000Z","date":"2023-05-19","kind":"grant","planned":false,"acquired":true,"shares":2123,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of restricted stock units (\"RSUs\") granted under the Issuer's 2021 Incentive Award Plan (the \"2021 Plan\").  Each RSU entitles the Reporting Person to receive one share of Issuer common stock upon vesting.  The RSUs shall vest in full upon the earlier to occur of (i) the first anniversary of the date of grant, (ii) the Issuer's next occurring annual meeting of stockholders, or (iii) a Change of Control (as defined in the 2021 Plan), subject to the Reporting Person's continued service with the Issuer on such vesting date."}],"balance_after":2123,"source":{"system":"sec-edgar","filing":"0001209191-23-031175","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000120919123031175/doc4.xml","form_type":"4"}},{"id":1957156,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock (Right to Buy)","published_at":"2023-03-13T21:02:56.000Z","date":"2023-03-09","kind":"grant","acquired":true,"shares":125489,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":125489,"derivative":{"exercise_price":1.17,"exercise_date":"2023-03-09","expiration_date":"2033-03-09","underlying":"Common Stock","underlying_shares":125489},"source":{"system":"sec-edgar","filing":"0000950103-23-004007","document":"dp190523_4-hassan.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000095010323004007/dp190523_4-hassan.xml","form_type":"4"}},{"id":1957155,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-03-13T21:02:56.000Z","date":"2023-03-09","kind":"grant","acquired":true,"shares":106837,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit ('RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in full on March 9, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in full on March 9, 2024."}],"balance_after":106837,"derivative":{"underlying":"Common Stock","underlying_shares":106837},"source":{"system":"sec-edgar","filing":"0000950103-23-004007","document":"dp190523_4-hassan.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000095010323004007/dp190523_4-hassan.xml","form_type":"4"}},{"id":1957154,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-13T21:02:56.000Z","date":"2023-03-09","kind":"grant","acquired":true,"shares":48290,"price":1.17,"value":56499.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued to the reporting person in lieu of an annual retainer of $56,500."}],"balance_after":308597,"source":{"system":"sec-edgar","filing":"0000950103-23-004007","document":"dp190523_4-hassan.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000095010323004007/dp190523_4-hassan.xml","form_type":"4"}},{"id":1993818,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-02-25T01:09:44.000Z","date":"2023-02-22","kind":"exercise","acquired":false,"shares":61576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested in full on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested in full on February 22, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":61576},"source":{"system":"sec-edgar","filing":"0000950103-23-003029","document":"dp189562_4-hassan.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000095010323003029/dp189562_4-hassan.xml","form_type":"4"}},{"id":1993817,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-25T01:09:44.000Z","date":"2023-02-22","kind":"exercise","acquired":true,"shares":61576,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."}],"balance_after":260307,"source":{"system":"sec-edgar","filing":"0000950103-23-003029","document":"dp189562_4-hassan.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000095010323003029/dp189562_4-hassan.xml","form_type":"4"}},{"id":2222270,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-24T20:29:35.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":104921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3rd of the shares underlying the option will vest on June 22, 2023; thereafter, 1/3rd of the remaining underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on the June 22, 2025, subject to the optionee's continued service on the Board of Directors of the Company."}],"balance_after":104921,"derivative":{"exercise_price":8.45,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":104921},"source":{"system":"sec-edgar","filing":"0001209191-22-039243","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000120919122039243/doc4.xml","form_type":"4"}},{"id":2262299,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-20T23:20:04.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":21013,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in full upon the earlier to occur of (i) the first anniversary of the grant date or (ii) the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer on such vesting date."}],"balance_after":21013,"derivative":{"exercise_price":29.02,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":21013},"source":{"system":"sec-edgar","filing":"0001209191-22-031173","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000120919122031173/doc4.xml","form_type":"4"}},{"id":2315644,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-03-29T21:04:53.000Z","date":"2022-03-25","kind":"exercise","acquired":false,"shares":16212,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested in full on March 25, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested in full on March 25, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":16212},"source":{"system":"sec-edgar","filing":"0000950103-22-005404","document":"dp170033_4-hassan.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000095010322005404/dp170033_4-hassan.xml","form_type":"4"}},{"id":2315643,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-29T21:04:53.000Z","date":"2022-03-25","kind":"exercise","acquired":true,"shares":16212,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen common stock."}],"balance_after":198731,"source":{"system":"sec-edgar","filing":"0000950103-22-005404","document":"dp170033_4-hassan.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000095010322005404/dp170033_4-hassan.xml","form_type":"4"}},{"id":2375496,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock (Right to Buy)","published_at":"2022-02-24T22:48:05.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":83189,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":83189,"derivative":{"exercise_price":2.03,"exercise_date":"2022-02-22","expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":83189},"source":{"system":"sec-edgar","filing":"0000950103-22-003221","document":"dp167775_4-hassan.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000095010322003221/dp167775_4-hassan.xml","form_type":"4"}},{"id":2375495,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-02-24T22:48:05.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":61576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit ('RSU\") represents a contingent right to receive one share of Precigen common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in full on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in full on February 22, 2023."}],"balance_after":61576,"derivative":{"underlying":"Common Stock","underlying_shares":61576},"source":{"system":"sec-edgar","filing":"0000950103-22-003221","document":"dp167775_4-hassan.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000095010322003221/dp167775_4-hassan.xml","form_type":"4"}},{"id":2375494,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-24T22:48:05.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":27832,"price":2.03,"value":56498.96,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued to the reporting person in lieu of an annual retainer of $56,500."}],"balance_after":182519,"source":{"system":"sec-edgar","filing":"0000950103-22-003221","document":"dp167775_4-hassan.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000095010322003221/dp167775_4-hassan.xml","form_type":"4"}},{"id":2454727,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-04T00:50:25.000Z","date":"2021-12-29","kind":"purchase","acquired":true,"shares":19300,"price":14.1653,"value":273390.29,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average purchase price of the shares purchased from $14.1250 to $14.2300 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions as reported in this footnote."}],"balance_after":19300,"source":{"system":"sec-edgar","filing":"0000899243-22-000176","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000089924322000176/doc4.xml","form_type":"4"}},{"id":2511273,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-17T02:19:39.000Z","date":"2021-11-14","kind":"grant","acquired":true,"shares":541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest on the first anniversary of the vesting commencement date measured from November 14, 2021, subject to the Reporting Person's continued service with the Issuer on such vesting date."}],"balance_after":541,"derivative":{"exercise_price":36.32,"expiration_date":"2031-11-13","underlying":"Common Stock","underlying_shares":541},"source":{"system":"sec-edgar","filing":"0001209191-21-064942","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000120919121064942/doc4.xml","form_type":"4"}},{"id":2589785,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-08-26T21:14:45.000Z","date":"2021-08-17","kind":"grant","acquired":true,"shares":49869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in three annual installments after August 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date."}],"balance_after":49869,"derivative":{"exercise_price":49.54,"expiration_date":"2031-08-16","underlying":"Common Stock","underlying_shares":49869},"source":{"system":"sec-edgar","filing":"0000899243-21-034291","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000089924321034291/doc4.xml","form_type":"4"}},{"id":2710660,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-17T23:24:24.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in substantially equal monthly installments over three years, commencing on May 14, 2021, subject to the Reporting Person's continued service with the Issuer through each vest date."}],"balance_after":40000,"derivative":{"exercise_price":16.82,"expiration_date":"2031-05-13","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-21-033308","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000120919121033308/doc4.xml","form_type":"4"}},{"id":2769614,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock (Right to Buy)","published_at":"2021-03-29T23:46:16.000Z","date":"2021-03-25","kind":"grant","acquired":true,"shares":22107,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22107,"derivative":{"exercise_price":7.71,"exercise_date":"2021-03-25","expiration_date":"2031-03-25","underlying":"Common Stock","underlying_shares":22107},"source":{"system":"sec-edgar","filing":"0001123292-21-000565","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000112329221000565/edgar.xml","form_type":"4"}},{"id":2769613,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-03-29T23:46:16.000Z","date":"2021-03-25","kind":"grant","acquired":true,"shares":16212,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Precigen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in full on March 25, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in full on March 25, 2022."}],"balance_after":16212,"derivative":{"underlying":"Common Stock","underlying_shares":16212},"source":{"system":"sec-edgar","filing":"0001123292-21-000565","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000112329221000565/edgar.xml","form_type":"4"}},{"id":2769612,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-29T23:46:16.000Z","date":"2021-03-25","kind":"grant","acquired":true,"shares":7328,"price":7.71,"value":56498.88,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued to the reporting person in lieu of an annual retainer of $56,500."}],"balance_after":154687,"source":{"system":"sec-edgar","filing":"0001123292-21-000565","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000112329221000565/edgar.xml","form_type":"4"}},{"id":2786796,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-03-16T20:35:48.000Z","date":"2021-03-13","kind":"exercise","acquired":false,"shares":62189,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested in full on March 13, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested in full on March 13, 2021."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":62189},"source":{"system":"sec-edgar","filing":"0001123292-21-000487","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000112329221000487/edgar.xml","form_type":"4"}},{"id":2786795,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-16T20:35:48.000Z","date":"2021-03-13","kind":"exercise","acquired":true,"shares":62189,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Precigen, Inc. common stock."}],"balance_after":147359,"source":{"system":"sec-edgar","filing":"0001123292-21-000487","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000112329221000487/edgar.xml","form_type":"4"}},{"id":104976,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-05-08T00:40:21.000Z","date":"2020-05-05","kind":"grant","acquired":true,"shares":846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vested immediately.  Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis.  Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule."}],"balance_after":9191,"source":{"system":"sec-edgar","filing":"0001127602-20-015851","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760220015851/form4.xml","form_type":"4"}},{"id":3205972,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock (Right to Buy)","published_at":"2020-03-17T22:32:27.000Z","date":"2020-03-13","kind":"grant","acquired":true,"shares":96324,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":96324,"derivative":{"exercise_price":2.01,"exercise_date":"2020-03-13","expiration_date":"2030-03-13","underlying":"Common Stock","underlying_shares":96324},"source":{"system":"sec-edgar","filing":"0001123292-20-000568","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000112329220000568/edgar.xml","form_type":"4"}},{"id":3205971,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-03-17T22:32:27.000Z","date":"2020-03-13","kind":"grant","acquired":true,"shares":62189,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Precigen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in full on March 13, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in full on March 13, 2021."}],"balance_after":62189,"derivative":{"underlying":"Common Stock","underlying_shares":62189},"source":{"system":"sec-edgar","filing":"0001123292-20-000568","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000112329220000568/edgar.xml","form_type":"4"}},{"id":3205970,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-17T22:32:27.000Z","date":"2020-03-13","kind":"grant","acquired":true,"shares":28109,"price":2.01,"value":56499.09,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued to the reporting person in lieu of an annual retainer of $ 56,500."}],"balance_after":85170,"source":{"system":"sec-edgar","filing":"0001123292-20-000568","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000112329220000568/edgar.xml","form_type":"4"}},{"id":3218255,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-03-10T20:18:13.000Z","date":"2020-03-08","kind":"exercise","acquired":false,"shares":24703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of XON common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vested in full on March 8, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vested in full on March 8, 2020."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":24703},"source":{"system":"sec-edgar","filing":"0001123292-20-000537","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000112329220000537/edgar.xml","form_type":"4"}},{"id":3218254,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-10T20:18:13.000Z","date":"2020-03-08","kind":"exercise","acquired":true,"shares":24703,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of XON common stock."}],"balance_after":57061,"source":{"system":"sec-edgar","filing":"0001123292-20-000537","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000112329220000537/edgar.xml","form_type":"4"}},{"id":116906,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-05-07T22:21:10.000Z","date":"2019-05-03","kind":"grant","acquired":true,"shares":1127,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vested immediately.  Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis.  Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule."}],"balance_after":8345,"source":{"system":"sec-edgar","filing":"0001127602-19-017638","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219017638/form4.xml","form_type":"4"}},{"id":3578750,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-03-26T21:49:05.000Z","date":"2019-03-23","kind":"exercise","acquired":false,"shares":7911,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of XON common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vested in full on March 23, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vested in full on March 23, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7911},"source":{"system":"sec-edgar","filing":"0001123292-19-000572","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000112329219000572/edgar.xml","form_type":"4"}},{"id":3578749,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-26T21:49:05.000Z","date":"2019-03-23","kind":"exercise","acquired":true,"shares":7911,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of XON common stock."}],"balance_after":32358,"source":{"system":"sec-edgar","filing":"0001123292-19-000572","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000112329219000572/edgar.xml","form_type":"4"}},{"id":3590922,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock (Right to Buy)","published_at":"2019-03-18T21:25:40.000Z","date":"2019-03-08","kind":"grant","acquired":true,"shares":42450,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":42450,"derivative":{"exercise_price":5.06,"exercise_date":"2019-03-08","expiration_date":"2029-03-08","underlying":"Common Stock","underlying_shares":42450},"source":{"system":"sec-edgar","filing":"0001123292-19-000526","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000112329219000526/edgar.xml","form_type":"4"}},{"id":3590921,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-03-18T21:25:40.000Z","date":"2019-03-08","kind":"grant","acquired":true,"shares":24703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of XON common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in full one year from the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in full one year from the grant date."}],"balance_after":32614,"derivative":{"underlying":"Common Stock","underlying_shares":24703},"source":{"system":"sec-edgar","filing":"0001123292-19-000526","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000112329219000526/edgar.xml","form_type":"4"}},{"id":3590920,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-18T21:25:40.000Z","date":"2019-03-08","kind":"grant","acquired":true,"shares":11166,"price":5.06,"value":56499.96,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued to the reporting person in lieu of an annual retainer of $56,500."}],"balance_after":24447,"source":{"system":"sec-edgar","filing":"0001123292-19-000526","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000112329219000526/edgar.xml","form_type":"4"}},{"id":3891115,"issuer":{"id":15757,"kind":"organization","name":"WARNER MEDIA, LLC"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2018-06-18T14:29:34.000Z","date":"2018-06-14","kind":"disposition_to_issuer","acquired":false,"shares":1128.3387,"ownership":{"direct":false,"nature":"By Deferred Compensation Plan"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Pursuant to the Merger Agreement, each outstanding phantom stock unit with respect to the Company's common stock acquired pursuant to the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the \"Deferred Compensation Plan\") was deemed converted into an amount in cash equal to approximately $100.8845 and reinvested in the investment option under the Deferred Compensation Plan that earns interest at a specified rate.  Pursuant to the terms of the Deferred Compensation Plan, the amount credited to the account will be paid out in cash in a lump sum or in annual installments beginning on April 30, 2019."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 14, 2018, AT&T Inc., a Delaware corporation (\"AT&T\"), acquired Time Warner Inc. (the \"Company\") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the \"Merger Agreement\").  The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017.  In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash.  Each disposition reported in this Form 4 is an exempt disposition."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, each outstanding phantom stock unit with respect to the Company's common stock acquired pursuant to the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the \"Deferred Compensation Plan\") was deemed converted into an amount in cash equal to approximately $100.8845 and reinvested in the investment option under the Deferred Compensation Plan that earns interest at a specified rate.  Pursuant to the terms of the Deferred Compensation Plan, the amount credited to the account will be paid out in cash in a lump sum or in annual installments beginning on April 30, 2019."}],"balance_after":0,"derivative":{"exercise_date":"2018-06-14","expiration_date":"2018-06-14","underlying":"Common Stock, Par Value $.01","underlying_shares":1128.3387},"source":{"system":"sec-edgar","filing":"0000950157-18-000724","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1105705/000095015718000724/form4.xml","form_type":"4"}},{"id":3891114,"issuer":{"id":15757,"kind":"organization","name":"WARNER MEDIA, LLC"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true}}],"security":"Director Stock Options (Right to Buy)","published_at":"2018-06-18T14:29:34.000Z","date":"2018-06-14","kind":"disposition_to_issuer","acquired":false,"shares":2460,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 14, 2018, AT&T Inc., a Delaware corporation (\"AT&T\"), acquired Time Warner Inc. (the \"Company\") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the \"Merger Agreement\").  The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017.  In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash.  Each disposition reported in this Form 4 is an exempt disposition."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a \"Company Option\"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a \"Company Option\"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757)."}],"balance_after":0,"derivative":{"exercise_price":88,"expiration_date":"2025-06-19","underlying":"Common Stock, Par Value $.01","underlying_shares":2460},"source":{"system":"sec-edgar","filing":"0000950157-18-000724","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1105705/000095015718000724/form4.xml","form_type":"4"}},{"id":3891113,"issuer":{"id":15757,"kind":"organization","name":"WARNER MEDIA, LLC"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true}}],"security":"Director Stock Options (Right to Buy)","published_at":"2018-06-18T14:29:34.000Z","date":"2018-06-14","kind":"disposition_to_issuer","acquired":false,"shares":3108,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 14, 2018, AT&T Inc., a Delaware corporation (\"AT&T\"), acquired Time Warner Inc. (the \"Company\") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the \"Merger Agreement\").  The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017.  In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash.  Each disposition reported in this Form 4 is an exempt disposition."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a \"Company Option\"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a \"Company Option\"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757)."}],"balance_after":0,"derivative":{"exercise_price":72.37,"expiration_date":"2026-06-17","underlying":"Common Stock, Par Value $.01","underlying_shares":3108},"source":{"system":"sec-edgar","filing":"0000950157-18-000724","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1105705/000095015718000724/form4.xml","form_type":"4"}},{"id":3891112,"issuer":{"id":15757,"kind":"organization","name":"WARNER MEDIA, LLC"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true}}],"security":"Director Stock Options (Right to Buy)","published_at":"2018-06-18T14:29:34.000Z","date":"2018-06-14","kind":"disposition_to_issuer","acquired":false,"shares":2996,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 14, 2018, AT&T Inc., a Delaware corporation (\"AT&T\"), acquired Time Warner Inc. (the \"Company\") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the \"Merger Agreement\").  The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017.  In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash.  Each disposition reported in this Form 4 is an exempt disposition."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a \"Company Option\"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a \"Company Option\"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757)."}],"balance_after":0,"derivative":{"exercise_price":56.83,"expiration_date":"2023-05-23","underlying":"Common Stock, Par Value $.01","underlying_shares":2996},"source":{"system":"sec-edgar","filing":"0000950157-18-000724","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1105705/000095015718000724/form4.xml","form_type":"4"}},{"id":3891111,"issuer":{"id":15757,"kind":"organization","name":"WARNER MEDIA, LLC"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true}}],"security":"Director Stock Options (Right to Buy)","published_at":"2018-06-18T14:29:34.000Z","date":"2018-06-14","kind":"disposition_to_issuer","acquired":false,"shares":2898,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 14, 2018, AT&T Inc., a Delaware corporation (\"AT&T\"), acquired Time Warner Inc. (the \"Company\") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the \"Merger Agreement\").  The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017.  In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash.  Each disposition reported in this Form 4 is an exempt disposition."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a \"Company Option\"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a \"Company Option\"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757)."}],"balance_after":0,"derivative":{"exercise_price":67.84,"expiration_date":"2024-06-13","underlying":"Common Stock, Par Value $.01","underlying_shares":2898},"source":{"system":"sec-edgar","filing":"0000950157-18-000724","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1105705/000095015718000724/form4.xml","form_type":"4"}},{"id":3891110,"issuer":{"id":15757,"kind":"organization","name":"WARNER MEDIA, LLC"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true}}],"security":"Director Stock Options (Right to Buy)","published_at":"2018-06-18T14:29:34.000Z","date":"2018-06-14","kind":"disposition_to_issuer","acquired":false,"shares":4880,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 14, 2018, AT&T Inc., a Delaware corporation (\"AT&T\"), acquired Time Warner Inc. (the \"Company\") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the \"Merger Agreement\").  The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017.  In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash.  Each disposition reported in this Form 4 is an exempt disposition."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a \"Company Option\"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a \"Company Option\"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757)."}],"balance_after":0,"derivative":{"exercise_price":35.27,"expiration_date":"2021-05-20","underlying":"Common Stock, Par Value $.01","underlying_shares":4880},"source":{"system":"sec-edgar","filing":"0000950157-18-000724","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1105705/000095015718000724/form4.xml","form_type":"4"}},{"id":3891109,"issuer":{"id":15757,"kind":"organization","name":"WARNER MEDIA, LLC"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true}}],"security":"Director Stock Options (Right to Buy)","published_at":"2018-06-18T14:29:34.000Z","date":"2018-06-14","kind":"disposition_to_issuer","acquired":false,"shares":5336,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 14, 2018, AT&T Inc., a Delaware corporation (\"AT&T\"), acquired Time Warner Inc. (the \"Company\") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the \"Merger Agreement\").  The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017.  In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash.  Each disposition reported in this Form 4 is an exempt disposition."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a \"Company Option\"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a \"Company Option\"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757)."}],"balance_after":0,"derivative":{"exercise_price":33.81,"expiration_date":"2022-05-15","underlying":"Common Stock, Par Value $.01","underlying_shares":5336},"source":{"system":"sec-edgar","filing":"0000950157-18-000724","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1105705/000095015718000724/form4.xml","form_type":"4"}},{"id":3891108,"issuer":{"id":15757,"kind":"organization","name":"WARNER MEDIA, LLC"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true}}],"security":"Director Stock Options (Right to Buy)","published_at":"2018-06-18T14:29:34.000Z","date":"2018-06-14","kind":"disposition_to_issuer","acquired":false,"shares":5708,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 14, 2018, AT&T Inc., a Delaware corporation (\"AT&T\"), acquired Time Warner Inc. (the \"Company\") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the \"Merger Agreement\").  The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017.  In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash.  Each disposition reported in this Form 4 is an exempt disposition."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a \"Company Option\"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a \"Company Option\"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757)."}],"balance_after":0,"derivative":{"exercise_price":28.84,"expiration_date":"2020-05-21","underlying":"Common Stock, Par Value $.01","underlying_shares":5708},"source":{"system":"sec-edgar","filing":"0000950157-18-000724","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1105705/000095015718000724/form4.xml","form_type":"4"}},{"id":3891107,"issuer":{"id":15757,"kind":"organization","name":"WARNER MEDIA, LLC"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true}}],"security":"Director Stock Options (Right to Buy)","published_at":"2018-06-18T14:29:34.000Z","date":"2018-06-14","kind":"disposition_to_issuer","acquired":false,"shares":4019,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 14, 2018, AT&T Inc., a Delaware corporation (\"AT&T\"), acquired Time Warner Inc. (the \"Company\") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the \"Merger Agreement\").  The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017.  In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash.  Each disposition reported in this Form 4 is an exempt disposition."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a \"Company Option\"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, each outstanding option to purchase the Company's common stock (a \"Company Option\"), whether vested or unvested, was converted into an option to acquire a number of shares of AT&T common stock equal to the number of shares of Company common stock under such Company Option, subject to the vesting and other terms in the applicable Company Option award agreement, except that the exercise price and the number of shares of AT&T common stock issuable upon exercise of such Company Option were adjusted based on the option exchange ratio determined under a formula in the Merger Agreement (which yields approximately 3.0757)."}],"balance_after":0,"derivative":{"exercise_price":27.39,"expiration_date":"2019-10-28","underlying":"Common Stock, Par Value $.01","underlying_shares":4019},"source":{"system":"sec-edgar","filing":"0000950157-18-000724","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1105705/000095015718000724/form4.xml","form_type":"4"}},{"id":3891106,"issuer":{"id":15757,"kind":"organization","name":"WARNER MEDIA, LLC"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true}}],"security":"Common Stock, Par Value $.01","published_at":"2018-06-18T14:29:34.000Z","date":"2018-06-14","kind":"disposition_to_issuer","acquired":false,"shares":49089,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 14, 2018, AT&T Inc., a Delaware corporation (\"AT&T\"), acquired Time Warner Inc. (the \"Company\") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the \"Merger Agreement\").  The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017.  In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash.  Each disposition reported in this Form 4 is an exempt disposition."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 14, 2018, AT&T Inc., a Delaware corporation (\"AT&T\"), acquired Time Warner Inc. (the \"Company\") pursuant to that certain Agreement and Plan of Merger, dated October 22, 2016, by and among the Company, AT&T, West Merger Sub, Inc., a wholly owned subsidiary of AT&T, and West Merger Sub II, LLC, a wholly owned subsidiary of AT&T (the \"Merger Agreement\").  The acquisition is more fully described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on January 9, 2017.  In accordance with the terms of the Merger Agreement, each share of the Company's common stock was exchanged for 1.437 shares of AT&T common stock plus $53.75 in cash.  Each disposition reported in this Form 4 is an exempt disposition."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950157-18-000724","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1105705/000095015718000724/form4.xml","form_type":"4"}},{"id":3908893,"issuer":{"id":15757,"kind":"organization","name":"WARNER MEDIA, LLC"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2018-06-04T17:06:19.000Z","date":"2018-06-01","kind":"exercise","acquired":false,"shares":2117,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The Reporting Person received one share of common stock for each restricted stock unit that vested."}],"balance_after":0,"derivative":{"exercise_date":"2018-06-01","expiration_date":"2018-06-01","underlying":"Common Stock, Par Value $.01","underlying_shares":2117},"source":{"system":"sec-edgar","filing":"0001127602-18-019804","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1105705/000112760218019804/form4.xml","form_type":"4"}},{"id":3908892,"issuer":{"id":15757,"kind":"organization","name":"WARNER MEDIA, LLC"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true}}],"security":"Common Stock, Par Value $.01","published_at":"2018-06-04T17:06:19.000Z","date":"2018-06-01","kind":"exercise","acquired":true,"shares":2117,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The common stock was acquired as a result of the vesting of restricted stock units awarded on June 16, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The Reporting Person received one share of common stock for each restricted stock unit that vested."}],"balance_after":49089,"source":{"system":"sec-edgar","filing":"0001127602-18-019804","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1105705/000112760218019804/form4.xml","form_type":"4"}},{"id":3949945,"issuer":{"id":15757,"kind":"organization","name":"WARNER MEDIA, LLC"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2018-05-02T16:59:22.000Z","date":"2018-05-01","kind":"grant","acquired":true,"shares":4.7926,"price":94.36,"value":452.229736,"ownership":{"direct":false,"nature":"By Deferred Compensation Plan"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The phantom stock units were acquired by the Reporting Person under the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the \"Deferred Compensation Plan\") in connection with the Issuer's quarterly cash dividend payment on its common stock.  This transaction is exempt under Section 16(b).  Pursuant to the terms of the Deferred Compensation Plan, the phantom stock units are to be settled in cash in a lump sum or in annual installments beginning on the April 30th following the date the Reporting Person ceases to be a director.  The cash value received by the Reporting Person upon distribution will be based, one-for-one, on the fair market value of the common stock underlying the phantom stock units held in the Reporting Person's account."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The phantom stock units were acquired by the Reporting Person under the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the \"Deferred Compensation Plan\") in connection with the Issuer's quarterly cash dividend payment on its common stock.  This transaction is exempt under Section 16(b).  Pursuant to the terms of the Deferred Compensation Plan, the phantom stock units are to be settled in cash in a lump sum or in annual installments beginning on the April 30th following the date the Reporting Person ceases to be a director.  The cash value received by the Reporting Person upon distribution will be based, one-for-one, on the fair market value of the common stock underlying the phantom stock units held in the Reporting Person's account."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The phantom stock units were acquired by the Reporting Person under the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the \"Deferred Compensation Plan\") in connection with the Issuer's quarterly cash dividend payment on its common stock.  This transaction is exempt under Section 16(b).  Pursuant to the terms of the Deferred Compensation Plan, the phantom stock units are to be settled in cash in a lump sum or in annual installments beginning on the April 30th following the date the Reporting Person ceases to be a director.  The cash value received by the Reporting Person upon distribution will be based, one-for-one, on the fair market value of the common stock underlying the phantom stock units held in the Reporting Person's account."}],"balance_after":1128.3387,"derivative":{"underlying":"Common Stock, Par Value $.01","underlying_shares":4.7926},"source":{"system":"sec-edgar","filing":"0001127602-18-016005","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1105705/000112760218016005/form4.xml","form_type":"4"}},{"id":129455,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-05-01T22:37:11.000Z","date":"2018-04-27","kind":"grant","acquired":true,"shares":1127,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7218,"source":{"system":"sec-edgar","filing":"0001127602-18-015809","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218015809/form4.xml","form_type":"4"}},{"id":3980044,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock (Right to Buy)","published_at":"2018-03-29T21:54:57.000Z","date":"2018-03-23","kind":"grant","acquired":true,"shares":14246,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14246,"derivative":{"exercise_price":15.8,"exercise_date":"2018-03-23","expiration_date":"2028-03-23","underlying":"Common Stock","underlying_shares":14246},"source":{"system":"sec-edgar","filing":"0001123292-18-000596","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000112329218000596/edgar.xml","form_type":"4"}},{"id":3980043,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-03-29T21:54:57.000Z","date":"2018-03-23","kind":"grant","acquired":true,"shares":7911,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of XON common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in full one year from the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in full one year from the grant date."}],"balance_after":7911,"derivative":{"underlying":"Common Stock","underlying_shares":7911},"source":{"system":"sec-edgar","filing":"0001123292-18-000596","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000112329218000596/edgar.xml","form_type":"4"}},{"id":3980042,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-29T21:54:57.000Z","date":"2018-03-23","kind":"grant","acquired":true,"shares":3575,"price":15.8,"value":56485.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued to the reporting person in lieu of an annual retainer of $56,500."}],"balance_after":13281,"source":{"system":"sec-edgar","filing":"0001123292-18-000596","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000112329218000596/edgar.xml","form_type":"4"}},{"id":4079712,"issuer":{"id":15757,"kind":"organization","name":"WARNER MEDIA, LLC"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2018-02-02T16:55:32.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":4.6476,"price":96.9,"value":450.35244,"ownership":{"direct":false,"nature":"By Deferred Compensation Plan"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The phantom stock units were acquired by the Reporting Person under the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the \"Deferred Compensation Plan\") in connection with the Issuer's quarterly cash dividend payment on its common stock.  This transaction is exempt under Section 16(b).  Pursuant to the terms of the Deferred Compensation Plan, the phantom stock units are to be settled in cash in a lump sum or in annual installments beginning on the April 30th following the date the Reporting Person ceases to be a director.  The cash value received by the Reporting Person upon distribution will be based, one-for-one, on the fair market value of the common stock underlying the phantom stock units held in the Reporting Person's account."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The phantom stock units were acquired by the Reporting Person under the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the \"Deferred Compensation Plan\") in connection with the Issuer's quarterly cash dividend payment on its common stock.  This transaction is exempt under Section 16(b).  Pursuant to the terms of the Deferred Compensation Plan, the phantom stock units are to be settled in cash in a lump sum or in annual installments beginning on the April 30th following the date the Reporting Person ceases to be a director.  The cash value received by the Reporting Person upon distribution will be based, one-for-one, on the fair market value of the common stock underlying the phantom stock units held in the Reporting Person's account."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The phantom stock units were acquired by the Reporting Person under the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the \"Deferred Compensation Plan\") in connection with the Issuer's quarterly cash dividend payment on its common stock.  This transaction is exempt under Section 16(b).  Pursuant to the terms of the Deferred Compensation Plan, the phantom stock units are to be settled in cash in a lump sum or in annual installments beginning on the April 30th following the date the Reporting Person ceases to be a director.  The cash value received by the Reporting Person upon distribution will be based, one-for-one, on the fair market value of the common stock underlying the phantom stock units held in the Reporting Person's account."}],"balance_after":1123.5461,"derivative":{"underlying":"Common Stock, Par Value $.01","underlying_shares":4.6476},"source":{"system":"sec-edgar","filing":"0001127602-18-003783","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1105705/000112760218003783/form4.xml","form_type":"4"}},{"id":4175054,"issuer":{"id":15757,"kind":"organization","name":"WARNER MEDIA, LLC"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2017-11-02T17:00:48.000Z","date":"2017-11-01","kind":"grant","acquired":true,"shares":4.5558,"price":98.45,"value":448.51851,"ownership":{"direct":false,"nature":"By Deferred Compensation Plan"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The phantom stock units were acquired by the Reporting Person under the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the \"Deferred Compensation Plan\") in connection with the Issuer's quarterly cash dividend payment on its common stock.  This transaction is exempt under Section 16(b).  Pursuant to the terms of the Deferred Compensation Plan, the phantom stock units are to be settled in cash in a lump sum or in annual installments beginning on the April 30th following the date the Reporting Person ceases to be a director.  The cash value received by the Reporting Person upon distribution will be based, one-for-one, on the fair market value of the common stock underlying the phantom stock units held in the Reporting Person's account."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The phantom stock units were acquired by the Reporting Person under the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the \"Deferred Compensation Plan\") in connection with the Issuer's quarterly cash dividend payment on its common stock.  This transaction is exempt under Section 16(b).  Pursuant to the terms of the Deferred Compensation Plan, the phantom stock units are to be settled in cash in a lump sum or in annual installments beginning on the April 30th following the date the Reporting Person ceases to be a director.  The cash value received by the Reporting Person upon distribution will be based, one-for-one, on the fair market value of the common stock underlying the phantom stock units held in the Reporting Person's account."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The phantom stock units were acquired by the Reporting Person under the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the \"Deferred Compensation Plan\") in connection with the Issuer's quarterly cash dividend payment on its common stock.  This transaction is exempt under Section 16(b).  Pursuant to the terms of the Deferred Compensation Plan, the phantom stock units are to be settled in cash in a lump sum or in annual installments beginning on the April 30th following the date the Reporting Person ceases to be a director.  The cash value received by the Reporting Person upon distribution will be based, one-for-one, on the fair market value of the common stock underlying the phantom stock units held in the Reporting Person's account."}],"balance_after":1118.8985,"derivative":{"underlying":"Common Stock, Par Value $.01","underlying_shares":4.5558},"source":{"system":"sec-edgar","filing":"0001127602-17-031018","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1105705/000112760217031018/form4.xml","form_type":"4"}},{"id":4246034,"issuer":{"id":15757,"kind":"organization","name":"WARNER MEDIA, LLC"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2017-08-02T16:59:11.000Z","date":"2017-08-01","kind":"grant","acquired":true,"shares":4.3528,"price":102.64,"value":446.771392,"ownership":{"direct":false,"nature":"By Deferred Compensation Plan"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The phantom stock units were acquired by the Reporting Person under the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the \"Deferred Compensation Plan\") in connection with the Issuer's quarterly cash dividend payment on its common stock.  This transaction is exempt under Section 16(b).  Pursuant to the terms of the Deferred Compensation Plan, the phantom stock units are to be settled in cash in a lump sum or in annual installments beginning on the April 30th following the date the Reporting Person ceases to be a director.  The cash value received by the Reporting Person upon distribution will be based, one-for-one, on the fair market value of the common stock underlying the phantom stock units held in the Reporting Person's account."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The phantom stock units were acquired by the Reporting Person under the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the \"Deferred Compensation Plan\") in connection with the Issuer's quarterly cash dividend payment on its common stock.  This transaction is exempt under Section 16(b).  Pursuant to the terms of the Deferred Compensation Plan, the phantom stock units are to be settled in cash in a lump sum or in annual installments beginning on the April 30th following the date the Reporting Person ceases to be a director.  The cash value received by the Reporting Person upon distribution will be based, one-for-one, on the fair market value of the common stock underlying the phantom stock units held in the Reporting Person's account."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The phantom stock units were acquired by the Reporting Person under the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the \"Deferred Compensation Plan\") in connection with the Issuer's quarterly cash dividend payment on its common stock.  This transaction is exempt under Section 16(b).  Pursuant to the terms of the Deferred Compensation Plan, the phantom stock units are to be settled in cash in a lump sum or in annual installments beginning on the April 30th following the date the Reporting Person ceases to be a director.  The cash value received by the Reporting Person upon distribution will be based, one-for-one, on the fair market value of the common stock underlying the phantom stock units held in the Reporting Person's account."}],"balance_after":1114.3427,"derivative":{"underlying":"Common Stock, Par Value $.01","underlying_shares":4.3528},"source":{"system":"sec-edgar","filing":"0001127602-17-024752","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1105705/000112760217024752/form4.xml","form_type":"4"}},{"id":4276279,"issuer":{"id":15757,"kind":"organization","name":"WARNER MEDIA, LLC"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2017-06-20T17:07:42.000Z","date":"2017-06-16","kind":"grant","acquired":true,"shares":2117,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The Reporting Person receives one share of common stock for each restricted stock unit that vests."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award of restricted stock unit vests in full on June 1, 2018. The vested shares of common stock will be issued to the Reporting Person upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award of restricted stock unit vests in full on June 1, 2018. The vested shares of common stock will be issued to the Reporting Person upon vesting."}],"balance_after":2117,"derivative":{"underlying":"Common Stock, Par Value $.01","underlying_shares":2117},"source":{"system":"sec-edgar","filing":"0001127602-17-021900","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1105705/000112760217021900/form4.xml","form_type":"4"}},{"id":4277735,"issuer":{"id":15757,"kind":"organization","name":"WARNER MEDIA, LLC"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true}}],"security":"Phantom Stock Units","published_at":"2017-06-19T17:04:23.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":1109.9899,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Deferred Compensation Plan"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The phantom stock units were acquired by the Reporting Person in a transaction exempt under Section 16(b) pursuant to the terms of the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the \"Deferred Compensation Plan\") and are to be settled in cash in a lump sum or in annual installments beginning on April 30th following the date the Reporting Person ceases to be a director.  The cash value received by the Reporting Person upon distribution will be based, one-for-one, upon the fair market value of the Common Stock underlying the phantom stock units held in the Reporting Person's account."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The phantom stock units were acquired by the Reporting Person in a transaction exempt under Section 16(b) pursuant to the terms of the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the \"Deferred Compensation Plan\") and are to be settled in cash in a lump sum or in annual installments beginning on April 30th following the date the Reporting Person ceases to be a director.  The cash value received by the Reporting Person upon distribution will be based, one-for-one, upon the fair market value of the Common Stock underlying the phantom stock units held in the Reporting Person's account."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The phantom stock units were acquired by the Reporting Person in a transaction exempt under Section 16(b) pursuant to the terms of the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the \"Deferred Compensation Plan\") and are to be settled in cash in a lump sum or in annual installments beginning on April 30th following the date the Reporting Person ceases to be a director.  The cash value received by the Reporting Person upon distribution will be based, one-for-one, upon the fair market value of the Common Stock underlying the phantom stock units held in the Reporting Person's account."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The phantom stock units were acquired by the Reporting Person in a transaction exempt under Section 16(b) pursuant to the terms of the Time Warner Inc. Non-Employee Directors' Deferred Compensation Plan (the \"Deferred Compensation Plan\") and are to be settled in cash in a lump sum or in annual installments beginning on April 30th following the date the Reporting Person ceases to be a director.  The cash value received by the Reporting Person upon distribution will be based, one-for-one, upon the fair market value of the Common Stock underlying the phantom stock units held in the Reporting Person's account."}],"balance_after":1109.9899,"derivative":{"underlying":"Common Stock, Par Value $.01","underlying_shares":1109.9899},"source":{"system":"sec-edgar","filing":"0001127602-17-021777","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1105705/000112760217021777/form4.xml","form_type":"4"}},{"id":4296205,"issuer":{"id":15757,"kind":"organization","name":"WARNER MEDIA, LLC"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2017-06-02T14:43:49.000Z","date":"2017-06-01","kind":"exercise","acquired":false,"shares":1382,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The Reporting Person received one share of common stock for each restricted stock unit that vested."}],"balance_after":0,"derivative":{"exercise_date":"2017-06-01","expiration_date":"2017-06-01","underlying":"Common Stock, Par Value $.01","underlying_shares":1382},"source":{"system":"sec-edgar","filing":"0001127602-17-020249","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1105705/000112760217020249/form4.xml","form_type":"4"}},{"id":4296204,"issuer":{"id":15757,"kind":"organization","name":"WARNER MEDIA, LLC"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true}}],"security":"Common Stock, Par Value $.01","published_at":"2017-06-02T14:43:49.000Z","date":"2017-06-01","kind":"exercise","acquired":true,"shares":1382,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The common stock was acquired as a result of the vesting of restricted stock units awarded on June 18, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The Reporting Person received one share of common stock for each restricted stock unit that vested."}],"balance_after":46972,"source":{"system":"sec-edgar","filing":"0001127602-17-020249","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1105705/000112760217020249/form4.xml","form_type":"4"}},{"id":141002,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-05-04T00:26:43.000Z","date":"2017-05-01","kind":"grant","acquired":true,"shares":1230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vested immediately.  Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis.  Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule."}],"balance_after":6091,"source":{"system":"sec-edgar","filing":"0001127602-17-016733","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760217016733/form4.xml","form_type":"4"}},{"id":4378168,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock (Right to Buy)","published_at":"2017-03-20T20:22:46.000Z","date":"2017-03-16","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15000,"derivative":{"exercise_price":21.38,"exercise_date":"2017-03-16","expiration_date":"2027-03-16","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001225385-17-000051","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000122538517000051/edgar.xml","form_type":"4"}},{"id":4378167,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-20T20:22:46.000Z","date":"2017-03-16","kind":"grant","acquired":true,"shares":2806,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9706,"source":{"system":"sec-edgar","filing":"0001225385-17-000051","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000122538517000051/edgar.xml","form_type":"4"}},{"id":4533741,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-05T16:14:05.000Z","date":"2016-12-01","kind":"purchase","acquired":true,"shares":6900,"price":29.0241,"value":200266.29,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $28.86 to $29.14, inclusive. The reporting person undertakes to provide Intrexon Corporation (\"Intrexon\"), any security holder of Intrexon, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":6900,"source":{"system":"sec-edgar","filing":"0001225385-16-000084","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110744/000122538516000084/edgar.xml","form_type":"4"}},{"id":153073,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true}}],"security":"Common Stock","published_at":"2016-05-05T23:59:19.000Z","date":"2016-05-03","kind":"grant","acquired":true,"shares":1279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vested immediately.  Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis.  Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule."}],"balance_after":4861,"source":{"system":"sec-edgar","filing":"0001127602-16-051278","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760216051278/form4.xml","form_type":"4"}},{"id":161567,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true}}],"security":"Common Stock","published_at":"2015-08-20T21:58:19.000Z","date":"2015-08-19","kind":"purchase","acquired":true,"shares":10,"price":165.5,"value":1655.0,"ownership":{"direct":true},"balance_after":3582,"source":{"system":"sec-edgar","filing":"0001127602-15-025541","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760215025541/form4.xml","form_type":"4"}},{"id":161566,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true}}],"security":"Common Stock","published_at":"2015-08-20T21:58:19.000Z","date":"2015-08-19","kind":"purchase","acquired":true,"shares":3000,"price":166.6357,"value":499907.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is an average price. The prices ranged from $166.51 to $166.76 per share. Full information regarding the number of shares purchased at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer."}],"balance_after":3572,"source":{"system":"sec-edgar","filing":"0001127602-15-025541","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760215025541/form4.xml","form_type":"4"}},{"id":162073,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11868,"kind":"person","name":"Hassan Fred","position":1,"cik":"0001110744","reported_name":"Hassan Fred","relationship":{"director":true}}],"security":"Common Stock","published_at":"2015-08-06T20:47:22.000Z","date":"2015-08-04","kind":"grant","acquired":true,"shares":572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and vested immediately.  Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis.  Vested RSUs may be deferred by the director, in which case, payment will occur accrding to the elected deferral schedule."}],"balance_after":572,"source":{"system":"sec-edgar","filing":"0001127602-15-024372","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760215024372/form4.xml","form_type":"4"}}],"next_cursor":"2015-08-06T20:47:22.000000Z,162073"}